MarketInOut Stock Screener Log In | Sign Up

Veracyte Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Veracyte Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,020.34 mln
Float78.92 mln
Earnings Date11/04/2026

EPS

1.40
Stretched

P / E

35.72
Overvalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.57
Likely reliable

1-Year Forecast

59.73
Attractive

Relative Strength

96 / 100
Top performer

Business Description

Veracyte is a medical testing company based in South San Francisco, California, that helps doctors detect and diagnose several types of cancer, including thyroid, prostate, bladder, breast, and lung cancer. The company develops genomic tests that analyze biological samples to give physicians clearer information when making treatment decisions. Founded in 2006, Veracyte sells its products and services to customers in the United States and around the world.

Key Fundamentals

EPS1.40
P/E35.72
ROE8.78
RPS7.08
ROIC9.74
ROA8.09
EBITDA, mln137
EV / EBITDA27.01
EV / EBIT31.86
Revenue, mln562
EV / Revenue6.58

Quote Details

Last 50.01
Change -2.16 (-4.14%)
Open 51.54
Volume 1,015,333
Turnover 50,776,800
Average Volume 1,169,782

Financial Ratios

Pre-Tax Profit Margin21
Leverage Ratio1.07
Current Ratio9.16
Price / Book2.91
Price / Tangible Book7.50
Price / Cash Flow22.33
Price / Free Cash Flow24.55
Debt / Equity0.03
Price / Sales7.26

Financial Strength

Altman Z-Score25.5
Piotroski F-Score 8 / 9
Beneish M-Score-2.57
Price to Intrinsic Value2.40
Price to Graham Number3.60
1-Year Target Price59.73
Short Ratio6.64
Short % of Float14.44

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.34% 87 / 100   
1 Month 13.17% 94 / 100   
2 Months -10.07% 32 / 100   
6 Months 51.13% 96 / 100   
1 Year 41.23% 90 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog